Related Experiment Videos
[Electromechanical mapping as a platform for myocardial laser therapy]
A J Keck1, K Hertting, R Kitzing
1Allgemeines Krankenhaus St. Georg, II. Medizinische Abteilung, Hamburg. DRKECK1@cs.com
Herz
|November 15, 2000
Summary
Percutaneous myocardial laser therapy offers a new revascularization strategy for end-stage coronary artery disease. A novel mapping system enhances laser therapy precision and safety by differentiating viable tissue from scar, improving patient outcomes.
Area of Science:
- Cardiovascular Medicine
- Interventional Cardiology
- Biomedical Engineering
Context:
- End-stage coronary artery disease (CAD) poses significant challenges for myocardial revascularization.
- Percutaneous myocardial laser therapy is an emerging treatment strategy.
- Precise targeting of laser application is critical for efficacy and safety.
Purpose:
- To introduce a novel catheter-based, non-fluoroscopic, three-dimensional endocardial mapping system (NOGA) for guiding percutaneous myocardial laser therapy.
- To assess the system's ability to differentiate viable myocardium from scar tissue.
- To evaluate the potential of this integrated approach to improve laser therapy safety and efficacy.
Summary:
- The NOGA system provides simultaneous assessment of local electrical activity and regional contractility.
- Analysis of uni- or bipolar voltage and linear local shortening enables precise differentiation of scar from viable myocardium.
- High spatial resolution of the NOGA system prevents redundant laser application at the same site, enhancing procedural safety.
Impact:
- This technology facilitates accurate identification and maneuvering of the laser catheter to target zones.
- Improved targeting and safety may lead to better outcomes in patients with end-stage CAD.
- A multicenter randomized study (Euro-direct) is ongoing to further evaluate the efficacy of NOGA-guided myocardial lasing.